Comparative proteomic analysis of nucleic acid-binding proteins in ten human tumor cell lines

International Journal of Oncology

Volumn 28, Issue 1, 2006, Pages 173-190

  Afjehi Sadat, Leila ^a   Engidawork, Ephrem ^a,b   Slavc, Irene ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Expression; Markers; Nucleic acid binding proteins; Proteomics; Tumor cell line

Indexed keywords

NUCLEIC ACID; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROGNOSIS; PROTEOMICS;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NUCLEIC ACIDS; PROGNOSIS; PROTEOMICS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33644794817     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.1.173     Document Type: Article

References (41)

1. Siomi H and Dreyfuss G: RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 7: 345-353, 1997.
2. Thisted T, Lyakhov DL and Liebhaber SA: Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest distinct modes of RNA recognition. J Biol Chem 276: 17484-17496, 2001.
3. Draper DE and Reynaldo LP: RNA binding strategies of ribosomal proteins. Nucleic Acids Res 27: 381-388, 1999.
4. Dreyfuss G, Swanson MS and Pinol-Roma S: Heterogeneous nuclear ribonucleoprotein particles and the pathway of mRNA formation. Trends Biochem Sci 13: 86-91, 1988.
5. Burd CG and Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621, 1994.
6. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Weitzdoerfer R, Fountoulakis M and Lubec G: Reduction of actin-related protein complex 2/3 in fetal Down Syndrome brain. Biochem Biophys Res Commun 293: 836-841, 2002.
8. Yang JW, Czech T and Lubec G: Proteomic profiling of human hippocampus. Electrophoresis 25: 1169-1174, 2004.
9. Berndt P, Hobohm U and Langen H: Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521-3526, 1999.
10. Honore B, Baandrup U and Vorum H: Heterogeneous nuclear ribonucleoproteins F and H/H′ show differential expression in normal and selected cancer tissues. Exp Cell Res 294: 199-209, 2004.
11. Pilch B, Allemand E, Facompre M, Bailly C, Riou JF, Soret J and Tazi J: Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res 61: 6876-6884, 2001.
12. Krecic AM and Swanson MS: HnRNP complexes: composition, structure and function. Curr Opin Cell Biol 11: 363-371, 1999.
13. Perrotti D and Calabretta B: Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 21: 8577-8583, 2002.
14. Evans JR, Mitchell SA, Spriggs KA, Ostrowski J, Bomsztyk K, Ostarek D and Willis AE: Members of the Poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22: 8012-8020, 2003.
15. Kim JH, Paek KY, Choi K, Kim TD, Hahm B, Kim KT and Jang SK: Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol 23: 708-720, 2003.
16. Mandal M, Vadlamudi R, Nguyen D, Wang RA, Costa L, Bagheri-Yarmand R, Mendelsohn J and Kumar R: Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 276: 9699-9704, 2001.
17. Harris MN, Ozpolat B, Abdi F, Gu S, Legler A, Mawuenyega KG, Tirado-Gomez M, Lopez-Berestein G and Chen X: Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic post-transcriptional control mechanisms in acute promyelocytic leukemia. Blood 104: 1314-1323, 2004.
18. Trotta R, Vignudelli T, Candini O, Intine RV, Pecorari L, Guerzoni C, Santilli G, Byrom MW, Goldoni S, Ford LP, Caligiuri MA, Maraia RJ, Perroti D and Calabretta B: BCR/ ABL activated mdm2 mRNA translation via the La antigen. Cancer Cell 3: 145-160, 2003.
19. Rhoads RE: Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 268: 3017-3020, 1993.
20. Kerekatte V, Smiley K, Hu B, Smith A, Gelder F and De Benedetti A: The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 64: 27-31, 1995.
21. Eberle J, Krasagakis K and Orfanos CE: Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 71: 396-401, 1997.
22. Fakuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H and Igarashi K: Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57: 5041-5044, 1997.
23. Bauer C, Brass N, Diesinger I, Kayser K, Grasser FA and Meese E: Overexpression of the eukaryotic translation initiation factor 4G-1 (eIF4G-1) in squamous cell lung carcinoma. Int J Cancer 98: 181-185, 2002.
24. Joseph P, O'Kernick CM, Othumpangat S, Lei YX, Yuan BZ and Ong TM: Expression profile of eukaryotic translation factors in human cancer tissues and cell lines. Mol Carcinog 40: 171-179, 2004.
25. Arora S, Yang JM, Kinzy TG, Utsumi R, Okamoto T, Kitayama T, Oritz PA and Hait WN: Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 63: 6894-6899, 2003.
26. Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu VH, Novotny EA, Crabtree JS, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL and Marx SJ: The 32-kDa subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 23: 493-509, 2003.
27. Moosmann P, Georgiev O, Le Douarin B, Bourquin JP and Schaffner W: Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res 24: 4859-4867, 1996.
28. Lim FL, Soulez M, Koczan D, Thiesen HJ and Knight JC: A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX gene that are disrupted in human carcinoma. Oncogene 17: 2013-2018, 1998.
29. Fukuda S, Wu DW, Stark K and Pelus LM: Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochem Biophys Res Commun 292: 593-600, 2002.
30. Brockstedt E, Otto A, Rickers A, Bommert K and Wittmann- Liebold B: Preparative high-resolution two-dimensional electrophoresis enables the identification of RNA polmerase B transcription factor 3 as an apoptosis-associated protein in the human BL60-2 Burkitt lymphoma cell line. J Protein Chem 18: 225-231, 1999.
31. Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M and Levens D: A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8: 465-480, 1994.
32. Wood MA, McMahon SB and Cole MD: An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 5: 321-330, 2000.
33. Kim KK, Shin BA, Seo KH, Kim PN, Koh JT, Kim JH and Park BR: Molecular cloning and characterization of splice variants of human RAD50 gene. Gene 235: 59-67, 1999.
34. Alani E, Padmore R and Kleckner N: Analysis of two wild-type and rad50 mutants of yeast suggests an intimate relationship between meiotic chromosome synapsis and recombination. Cell 61: 419-436, 1990.
35. Raymond WE and Kleckner N: RAD50 protein of S. cerevisiae exhibits ATP-dependent DNA binding. Nucleic Acids Res 21: 3851-3856, 1993.
36. Ferbus DA and Goubin G: Production and characterization of mouse monoclonal antibodies to human zinc finger OZF protein overexpressed in pancreatic carcinoma. Hybridoma 18: 431-436, 1999.
37. Chen EY, Zollo M, Mazzarella R, Ciccodicola A, Chen CN, Zuo L, Heiner C, Burough F, Repetto M, Schlessinger D and D'Urso M: Long-range sequence analysis in Xq28: thirteen known and six candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and G6PD loci. Mol Genet 5: 659-668, 1996.
38. Ryan RF, Schultz DC, Ayyanathan K, Singh PB, Friedman JR, Fredericks WJ and Rauscher FJ III: KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. Mol Cell Biol 19: 4366-4378, 1999.
39. Afjehi-Sadat L, Krapfenbauer K, Fountoulakis M, Frischer T, Slavc I and Lubec G: Validation of hypothetical nucleic acid binding proteins in human bronchial epithelial, mesothelial, amnion, kidney and lymphocyte cell lines by proteomics. Curr Proteomics 1: 297-313, 2004.
40. Peyrl A, Krapfenbauer K, Slavc I, Strobel T and Lubec G: Proteomic characterization of the human cortical neuronal cell line HCN-2. J Chem Neuroanat 26: 171-178, 2003.
41. Yang JW, Suder P, Silberring J and Lubec G: Proteome analysis of mouse primary astrocytes. Neurochem Int (In press).